These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6938033)

  • 21. Bone imaging and serum phosphatases in prostatic carcinoma.
    Bishop MC; Hardy JG; Taylor MC; Wastie ML; Lemberger RJ
    Br J Urol; 1985 Jun; 57(3):317-24. PubMed ID: 4005501
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Staging of patients with carcinoma of the breast by bone scans? [author's transl)].
    Creutzig H
    Radiologe; 1978 May; 18(5):179-83. PubMed ID: 652985
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serial bone scintigraphy for assessing the effectiveness of treatment of osseous metastases from prostatic cancer.
    Langhammer H; Sintermann R; Hör G; Pabst HW
    Nuklearmedizin; 1978 Jul; 17(3):87-91. PubMed ID: 568257
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Computerized bone scan. A potentially useful technique to measure response in prostatic carcinoma.
    Drelichman A; Decker DA; Al-Sarraf M; Vaitkevicius VK; Muz J
    Cancer; 1984 Mar; 53(5):1061-5. PubMed ID: 6229325
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlation between BMD and bone scintigraphy in patients with prostate cancer.
    Perk H; Yildiz M; Kosar A; Cerci S; Soyupek F; Ozorak A; Dilmen C
    Urol Oncol; 2008; 26(3):250-3. PubMed ID: 18452814
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bone scanning in management of metastatic osteogenic sarcoma.
    Siddiqui AR; Wellman HN; Weetman RM; Smith WL
    Clin Nucl Med; 1979 Jan; 4(1):6-11. PubMed ID: 283899
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Technetium-99M polyphosphate bone scanning in carcinoma of the prostate.
    Lentle BC; McGowan DG; Dierich H
    Br J Urol; 1974 Oct; 46(5):543-8. PubMed ID: 4422347
    [No Abstract]   [Full Text] [Related]  

  • 28. Comparison of enzyme, clinical, radiographic, and radionuclide methods of detecting bone metastases from carcinoma of the prostate.
    Schaffer DL; Pendergrass HP
    Radiology; 1976 Nov; 121(2):431-4. PubMed ID: 981622
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative evaluation of bone marrow acid phosphatase and bone scanning in staging of prostatic cancer.
    Gursel EO; Rezvan M; Sy FA; Veenema RJ
    J Urol; 1974 Jan; 111(1):53-7. PubMed ID: 4813553
    [No Abstract]   [Full Text] [Related]  

  • 30. Urine hydroxyproline excretion--a marker of bone metastases in prostatic carcinoma.
    Bishop MC; Fellows GJ
    Br J Urol; 1977; 49(7):711-6. PubMed ID: 597712
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Efficient diagnosis of prostate carcinoma].
    Heising J; Schratz W; Böhm G
    Z Hautkr; 1983 Jul; 58(13):931-3, 936-8, 943-7. PubMed ID: 6613217
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Recent advances in isotopic exploration of the skeletal system in prostate cancer (author's transl)].
    Oliveux A; Grob JC; Moyses B; Methlin G; Bollack C
    Sem Hop; 1980 Feb 18-25; 56(7-8):346-50. PubMed ID: 6246630
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased skeletal:renal uptake ratio: etiology and characteristics.
    Cheng TH; Holman BL
    Radiology; 1980 Aug; 136(2):455-9. PubMed ID: 6447313
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Utility of bone scanning in detecting occult skeletal metastases from cervical carcinoma.
    Katz RD; Alderson PO; Rosenshein NB; Bowerman JW; Wagner HN
    Radiology; 1979 Nov; 133(2):469-72. PubMed ID: 493539
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Radioisotope scanning in the initial staging of bronchogenic carcinoma.
    Hooper RG; Beechler CR; Johnson MC
    Am Rev Respir Dis; 1978 Aug; 118(2):279-86. PubMed ID: 697178
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proceedings: Diagnosis and staging of prostatic carcinoma.
    Prout GR
    Cancer; 1973 Nov; 32(5):1096-103. PubMed ID: 4202187
    [No Abstract]   [Full Text] [Related]  

  • 37. Clinical studies of prostatic cancer imaging with radiolabeled antibodies against prostatic acid phosphatase.
    Goldenberg DM; DeLand FH
    Urol Clin North Am; 1984 May; 11(2):277-81. PubMed ID: 6328719
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Skeletal scintigraphy. The use of technetium 99M-labeled complexes in the detection of early osseous involvement by metastatic tumors.
    Hopkins GB; Kristensen KA; Campbell CG
    West J Med; 1974 Jun; 120(6):448-51. PubMed ID: 4845922
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Lymph node staging in prostatic carcinoma Lymphography, pedal and intraprostatic lymphoscintigraphy, transcutaneous fine-needle lymph node biopsy and pelvic "guided" lymphadenectomy. Considerations on a series of 20 cases (1 September 1978-31 January 1980)].
    Luciani L; Menichelli E; Fuochi C; Taddei L
    Minerva Med; 1981 Apr; 72(13):789-800. PubMed ID: 7012680
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Distribution pattern of metastatic bone disease. A need for total body skeletal image.
    Krishnamurthy GT; Tubis M; Hiss J; Blahd WH
    JAMA; 1977 Jun; 237(23):2504-6. PubMed ID: 576963
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.